Cargando…
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases
Phage therapy has been overshadowed by antibiotics for decades. However, it is being revisited as a powerful approach against antimicrobial-resistant bacteria. As bacterial microbiota have been mechanistically linked to gastrointestinal and liver diseases, precise editing of the gut microbiota via t...
Autores principales: | Fujiki, Jumpei, Schnabl, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641246/ https://www.ncbi.nlm.nih.gov/pubmed/37965159 http://dx.doi.org/10.1016/j.jhepr.2023.100909 |
Ejemplares similares
-
The Gut Microbiota and Liver Disease
por: Llorente, Cristina, et al.
Publicado: (2015) -
Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy
por: Fujiki, Jumpei, et al.
Publicado: (2023) -
From intestinal dysbiosis to alcohol-associated liver disease
por: Mendes, Beatriz Garcia, et al.
Publicado: (2020) -
Antimicrobial proteins: intestinal guards to protect against liver disease
por: Hendrikx, Tim, et al.
Publicado: (2018) -
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
por: Hartmann, Phillipp, et al.
Publicado: (2012)